Moskov, M., Lindberg, J. H., Lycke, M., Ivansson, E., Gyllensten, U., Sundfeldt, K., . . . Enroth, S. Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationMoskov, Mikaela, Julia Hedlund Lindberg, Maria Lycke, Emma Ivansson, Ulf Gyllensten, Karin Sundfeldt, Karin Stålberg, and Stefan Enroth. Deep Plasma Proteomics Identifies and Validates an Eight-protein Biomarker Panel That Separate Benign from Malignant Tumors in Ovarian Cancer. Nature Portfolio.
MLA (9th ed.) CitationMoskov, Mikaela, et al. Deep Plasma Proteomics Identifies and Validates an Eight-protein Biomarker Panel That Separate Benign from Malignant Tumors in Ovarian Cancer. Nature Portfolio.